• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用混合调强放射治疗(IMRT)和容积弧形调强放射治疗(VMAT)对左侧乳腺癌进行计划稳健性评估。

Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer.

作者信息

Ding Zhen, Zeng Qi, Kang Kailian, Xu Meiling, Xiang Xiaoyong, Liu Chenbin

机构信息

Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 113 Baohe Road, Longgang District, Shenzhen 518116, China.

出版信息

Bioengineering (Basel). 2022 Mar 24;9(4):131. doi: 10.3390/bioengineering9040131.

DOI:10.3390/bioengineering9040131
PMID:35447691
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9028731/
Abstract

PURPOSE

We aim to evaluate the robustness of multi-field IMRT and VMAT plans to target motion for left-sided BC radiotherapy.

METHODS

The 7-field hybrid IMRT (7F-H-IMRT) and 2-arc VMAT (2A-VMAT) plans were generated for ten left-sided BC patients. Shifts of 3 mm, 5 mm, and 10 mm in six directions were introduced and the perturbed dose distributions were recalculated. The dose differences (∆D) of the original plan and perturbed plan corresponded to the plan robustness for the structure.

RESULTS

Higher ∆D, ∆D, and ∆D of CTV were observed in 2A-VMAT plans, which induced higher tumor control probability reductions. A higher ∆Dmean of CTV Boost was found in 7F-H-IMRT plans despite lower ∆D and ∆D. Shifts in the S-I direction exerted the largest effect on CTV and CTV Boost. Regarding OARs, shifts in R, P, and I directions contributed to increasing the received dose. The 2A-VMAT plans performed better dose sparing, but had a higher robustness in a high-dose volume of the left lung and heart. The 2A-VMAT plans decreased the max dose of LAD but exhibited lower robustness.

CONCLUSION

The 2A-VMAT plans showed higher sensitivity to position deviation. Shifts in the S-I direction exerted the largest effect for CTV and CTV Boost.

摘要

目的

我们旨在评估多野调强放疗(IMRT)和容积旋转调强放疗(VMAT)计划针对左侧乳腺癌放疗中靶区运动的稳健性。

方法

为10例左侧乳腺癌患者生成7野混合IMRT(7F-H-IMRT)和2弧VMAT(2A-VMAT)计划。在六个方向上引入3毫米、5毫米和10毫米的移位,并重新计算受扰后的剂量分布。原始计划和受扰计划的剂量差异(∆D)对应于该结构的计划稳健性。

结果

在2A-VMAT计划中观察到CTV的∆D、∆D和∆D更高,这导致肿瘤控制概率降低得更多。尽管7F-H-IMRT计划的∆D和∆D较低,但CTV增敏区的∆Dmean更高。头脚方向的移位对CTV和CTV增敏区影响最大。关于危及器官(OARs),右、后和内方向的移位导致所接受剂量增加。2A-VMAT计划的剂量 sparing效果更好,但在左肺和心脏的高剂量体积方面具有更高的稳健性。2A-VMAT计划降低了左前降支(LAD)的最大剂量,但稳健性较低。

结论

2A-VMAT计划对位置偏差表现出更高的敏感性。头脚方向的移位对CTV和CTV增敏区影响最大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f51/9028731/2d4bb732cce4/bioengineering-09-00131-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f51/9028731/caba08df1bc7/bioengineering-09-00131-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f51/9028731/32ff3aab4704/bioengineering-09-00131-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f51/9028731/2d4bb732cce4/bioengineering-09-00131-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f51/9028731/caba08df1bc7/bioengineering-09-00131-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f51/9028731/32ff3aab4704/bioengineering-09-00131-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f51/9028731/2d4bb732cce4/bioengineering-09-00131-g003.jpg

相似文献

1
Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer.使用混合调强放射治疗(IMRT)和容积弧形调强放射治疗(VMAT)对左侧乳腺癌进行计划稳健性评估。
Bioengineering (Basel). 2022 Mar 24;9(4):131. doi: 10.3390/bioengineering9040131.
2
A Beam Angle Selection Method to Improve Plan Robustness Against Position Error in Intensity-Modulated Radiotherapy for Left-Sided Breast Cancer.一种用于改善左侧乳腺癌调强放疗中位置误差的计划稳健性的射束角度选择方法。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241259633. doi: 10.1177/15330338241259633.
3
Evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (VMAT) with set-up uncertainty in Nasopharyngeal carcinoma (NPC) radiotherapy.评估摆位不确定性对鼻咽癌容积弧形调强放疗(VMAT)剂量学的计划稳健性。
Radiat Oncol. 2022 Jan 3;17(1):1. doi: 10.1186/s13014-021-01970-8.
4
Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.容积旋转调强弧形治疗与常规调强适形放疗在食管癌中的比较:一项治疗计划的比较。
World J Gastroenterol. 2012 Oct 7;18(37):5266-75. doi: 10.3748/wjg.v18.i37.5266.
5
Robustness of VMAT to setup errors in postmastectomy radiotherapy of left-sided breast cancer: Impact of bolus thickness.VMAT 对左侧乳腺癌保乳术后放疗中摆位误差的稳健性:填充物厚度的影响。
PLoS One. 2023 Jan 24;18(1):e0280456. doi: 10.1371/journal.pone.0280456. eCollection 2023.
6
Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.左侧早期乳腺癌的混合容积调强弧形放疗、容积调强弧形放疗和调强放射治疗的剂量学比较
Med Dosim. 2015 Autumn;40(3):262-7. doi: 10.1016/j.meddos.2015.05.003. Epub 2015 Jun 23.
7
A comparative dosimetric study of left sided breast cancer after breast-conserving surgery treated with VMAT and IMRT.左侧乳腺癌保乳手术后VMAT与IMRT治疗的剂量学对比研究。
Radiat Oncol. 2015 Nov 17;10:231. doi: 10.1186/s13014-015-0531-4.
8
Locoregional irradiation including internal mammary nodal region for left-sided breast cancer after breast conserving surgery: Dosimetric evaluation of 4 techniques.保乳手术后左侧乳腺癌的局部区域照射,包括内乳淋巴结区域:4种技术的剂量学评估
Med Dosim. 2019;44(4):e13-e18. doi: 10.1016/j.meddos.2018.09.004. Epub 2018 Oct 24.
9
Dosimetric Comparison of Different Planning Techniques in Left-sided Whole-Breast Irradiation: A Planning Study.左侧全乳照射中不同计划技术的剂量学比较:一项计划研究。
J Med Phys. 2020 Jul-Sep;45(3):148-155. doi: 10.4103/jmp.JMP_49_20. Epub 2020 Oct 13.
10
Dosimetric Planning Comparison for Left-Sided Breast Cancer Radiotherapy: The Clinical Feasibility of Four-Dimensional-Computed Tomography-Based Treatment Planning Optimization.左侧乳腺癌放疗的剂量学计划比较:基于四维计算机断层扫描的治疗计划优化的临床可行性
Cureus. 2022 May 6;14(5):e24777. doi: 10.7759/cureus.24777. eCollection 2022 May.

引用本文的文献

1
Planning Automation for Treatment Techniques Comparison and Robustness Analysis: Tangential Intensity Modulated Radiation Therapy and Volumetric Modulated Arc Therapy for Whole Breast Irradiation.用于治疗技术比较和稳健性分析的计划自动化:全乳照射的切线调强放射治疗和容积调强弧形治疗
Adv Radiat Oncol. 2025 Jan 15;10(3):101719. doi: 10.1016/j.adro.2025.101719. eCollection 2025 Mar.
2
Dosimetric analysis of half-field-based VMAT with the deep inspiration breath-hold technique for left breast cancer patients following breast-conserving surgery.保乳手术后左乳腺癌患者基于半野的容积调强弧形放疗联合深吸气屏气技术的剂量学分析
Front Oncol. 2024 Nov 21;14:1418723. doi: 10.3389/fonc.2024.1418723. eCollection 2024.
3

本文引用的文献

1
Estimation of delivered dose to lung tumours considering setup uncertainties and breathing motion in a cohort of patients treated with stereotactic body radiation therapy.考虑到立体定向体部放射治疗患者的摆位不确定性和呼吸运动,估算肺肿瘤的送达剂量。
Phys Med. 2021 Aug;88:53-64. doi: 10.1016/j.ejmp.2021.06.015. Epub 2021 Jun 25.
2
CTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis.基于累积剂量分析的食管癌放疗CTV至PTV边界评估
Radiother Oncol. 2021 Aug;161:16-22. doi: 10.1016/j.radonc.2021.05.005. Epub 2021 May 14.
3
Deep-inspirational breath-hold (DIBH) technique in left-sided breast cancer: various aspects of clinical utility.
Dosimetric Study and Robustness Analysis of Base Note Intensive Locked Field Radiotherapy for Left Breast Cancer.
左乳腺癌基本调强锁定野放射治疗的剂量学研究与稳健性分析
Breast Cancer (Dove Med Press). 2024 Jul 30;16:433-450. doi: 10.2147/BCTT.S447955. eCollection 2024.
4
A Beam Angle Selection Method to Improve Plan Robustness Against Position Error in Intensity-Modulated Radiotherapy for Left-Sided Breast Cancer.一种用于改善左侧乳腺癌调强放疗中位置误差的计划稳健性的射束角度选择方法。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241259633. doi: 10.1177/15330338241259633.
5
Interfractional variation in whole-breast VMAT irradiation: a dosimetric study with complementary SGRT and CBCT patient setup.分次间全乳 VMAT 照射的变化:使用互补的 SGRT 和 CBCT 患者摆位的剂量学研究。
Radiat Oncol. 2024 Feb 13;19(1):21. doi: 10.1186/s13014-024-02418-5.
深吸气屏气(DIBH)技术在左侧乳腺癌中的应用:临床实用性的各个方面。
Radiat Oncol. 2021 May 13;16(1):89. doi: 10.1186/s13014-021-01816-3.
4
Benefits of Continuous Positive Airway Pressure (CPAP) During Radiation Therapy: A Prospective Trial.持续气道正压通气(CPAP)在放射治疗中的获益:一项前瞻性试验。
Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1466-1472. doi: 10.1016/j.ijrobp.2021.03.044. Epub 2021 May 5.
5
Risk of Cardiac Disease in Patients With Breast Cancer: Impact of Patient-Specific Factors and Individual Heart Dose From Three-Dimensional Radiation Therapy Planning.乳腺癌患者的心脏疾病风险:来自三维放射治疗计划的患者特定因素和个体心脏剂量的影响。
Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):473-481. doi: 10.1016/j.ijrobp.2020.12.053. Epub 2021 Jan 6.
6
Impact of Positioning Errors on the Dosimetry of Breath-Hold-Based Volumetric Arc Modulated and Tangential Field-in-Field Left-Sided Breast Treatments.定位误差对基于屏气的容积弧形调强放疗及左侧乳腺切线野中野放疗剂量学的影响
Front Oncol. 2020 Oct 29;10:554131. doi: 10.3389/fonc.2020.554131. eCollection 2020.
7
Feasibility of Optical Surface-Guidance for Position Verification and Monitoring of Stereotactic Body Radiotherapy in Deep-Inspiration Breath-Hold.光学表面引导用于深吸气屏气立体定向体部放射治疗的位置验证和监测的可行性
Front Oncol. 2020 Sep 25;10:573279. doi: 10.3389/fonc.2020.573279. eCollection 2020.
8
What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans.放疗中的计划质量是指什么?评估剂量指标、计划复杂性和稳健性的重要性。
Radiother Oncol. 2020 Dec;153:26-33. doi: 10.1016/j.radonc.2020.09.038. Epub 2020 Sep 25.
9
Assessment of robustness against setup uncertainties using probabilistic scenarios in lung cancer: a comparison of proton with photon therapy.使用肺癌中概率场景评估对设置不确定性的稳健性:质子与光子治疗的比较。
Br J Radiol. 2020 Mar;93(1107):20190584. doi: 10.1259/bjr.20190584. Epub 2020 Feb 4.
10
Long-term risk of ischemic heart disease after adjuvant radiotherapy in breast cancer: results from a large population-based cohort.乳腺癌辅助放疗后缺血性心脏病的长期风险:来自大型基于人群队列的研究结果。
Breast Cancer Res. 2020 Jan 22;22(1):10. doi: 10.1186/s13058-020-1249-2.